These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30381060)

  • 21. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug repositioning using drug-disease vectors based on an integrated network.
    Lee T; Yoon Y
    BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of validation strategies for computational drug repositioning.
    Brown AS; Patel CJ
    Brief Bioinform; 2018 Jan; 19(1):174-177. PubMed ID: 27881429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scoring functions for drug-effect similarity.
    Struckmann S; Ernst M; Fischer S; Mah N; Fuellen G; Möller S
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32484516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
    Wei GG; Gao L; Tang ZY; Lin P; Liang LB; Zeng JJ; Chen G; Zhang LC
    Pathol Res Pract; 2019 Jun; 215(6):152378. PubMed ID: 30871913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-target drug repositioning by bipartite block-wise sparse multi-task learning.
    Li L; He X; Borgwardt K
    BMC Syst Biol; 2018 Apr; 12(Suppl 4):55. PubMed ID: 29745839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational drug repositioning: from data to therapeutics.
    Hurle MR; Yang L; Xie Q; Rajpal DK; Sanseau P; Agarwal P
    Clin Pharmacol Ther; 2013 Apr; 93(4):335-41. PubMed ID: 23443757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DrugSig: A resource for computational drug repositioning utilizing gene expression signatures.
    Wu H; Huang J; Zhong Y; Huang Q
    PLoS One; 2017; 12(5):e0177743. PubMed ID: 28562632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis.
    Peng Y; Yuan M; Xin J; Liu X; Wang J
    Bioinformatics; 2020 Nov; 36(17):4626-4632. PubMed ID: 32516365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer.
    Yang C; Zhang H; Chen M; Wang S; Qian R; Zhang L; Huang X; Wang J; Liu Z; Qin W; Wang C; Hang H; Wang H
    Elife; 2022 Feb; 11():. PubMed ID: 35191375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.
    Shameer K; Readhead B; Dudley JT
    Curr Top Med Chem; 2015; 15(1):5-20. PubMed ID: 25579574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational drug repositioning for cancer therapeutics.
    Jiao M; Liu G; Xue Y; Ding C
    Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dr AFC: drug repositioning through anti-fibrosis characteristic.
    Wu D; Gao W; Li X; Tian C; Jiao N; Fang S; Xiao J; Xu Z; Zhu L; Zhang G; Zhu R
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32572450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional data: a new gateway to drug repositioning?
    Iorio F; Rittman T; Ge H; Menden M; Saez-Rodriguez J
    Drug Discov Today; 2013 Apr; 18(7-8):350-7. PubMed ID: 22897878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DrSim: Similarity Learning for Transcriptional Phenotypic Drug Discovery.
    Wei Z; Zhu S; Chen X; Zhu C; Duan B; Liu Q
    Genomics Proteomics Bioinformatics; 2022 Oct; 20(5):1028-1036. PubMed ID: 36182102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomedical data and computational models for drug repositioning: a comprehensive review.
    Luo H; Li M; Yang M; Wu FX; Li Y; Wang J
    Brief Bioinform; 2021 Mar; 22(2):1604-1619. PubMed ID: 32043521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network-based drug ranking and repositioning with respect to DrugBank therapeutic categories.
    Re M; Valentini G
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1359-71. PubMed ID: 24407295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.